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The Hippo (Hpo) signaling pathway limits organ growth in organisms from Drosophila to mammals by sup-
pressing the activity of the transcriptional coactivator Yorkie (Yki)/YAP. The TEAD/TEF factor Scalloped
(Sd) has been identified as the first known transcription factor to partner with Yki as a downstream target
of Hpo signaling.Cell growth, proliferation, and apoptosis
regulate organ size during development
and tissue homeostasis. In recent years,
Drosophila’s Hippo (Hpo) signal trans-
duction pathway has been delineated as
a central mechanism that regulates organ
size (see Saucedo and Edgar, 2007, for
review). Activation of Hpo signaling in-
duces a kinase cascade in which the
Ste-20-type kinase Hpo, complexed with
the WW-repeat protein Salvador (Sav),
phosphorylates and activates the nuclear
Dbf-2-related-type kinase Warts (Wts).
Wts, facilitated by binding to the Mob-
as-tumor-suppressor (Mats) protein,
phosphorylates and inhibits the transcrip-
tional coactivator Yorkie (Yki), a potent
activator of cell growth and proliferation.
The protocadherin Fat and the FERM-do-
main proteins Merlin (Mer) and Expanded
(Ex) act as upstream activators of Hpo
signaling.
Inactivation of Hpo signaling, or overex-
pression of yki, results in overgrowth of
Drosophila tissues by promoting both ad-
ditional cell divisions and the survival of
cells normally culled by apoptosis. Some
transcriptional targets of Hpo signaling
that regulate cell proliferation and apopto-
sis are known, including cyclin E (cycE),
the microRNA bantam, and the apoptosis
inhibitordiap1.Negative feedback, inwhich
Hpo signaling suppresses ex and mer
expression, has also been documented.
Mammalian homologs of all the known
pathway components exist, and several
can functionally replace their Drosophila
counterparts in vivo. Exciting new studies
show that activation of the mammalian Yki
homolog, Yes-associated protein (YAP),
can bypass contact inhibition in cell culture
(Zhao et al., 2007) and cause massive liver
overgrowth in mice (Dong et al., 2007).Which DNA-binding factor or factors
associate with Yki to mediate the re-
sponse to Hpo signaling? In mammals,
YAP binds and/or coactivates several
transcriptional regulators, including p73,
p53-binding protein-2 (p53BP2), RUNX2,
SMAD7, ERBB4, PEBP2a, and TEAD/
TEF proteins. The relevance of these
interactions to Hpo signaling in vivo,
however, was unknown. In this issue of
Developmental Cell, articles by the Jiang
and Pan labs (Zhang et al., 2008; Wu
et al., 2008) identify Scalloped (Sd), the
only TEAD/TEF protein family member in
Drosophila (Campbell et al., 1992), as
a transcription factor functioning in the
Hpo pathway.
These groups demonstrated that Sd
and Yki physically interact, and together
form functional transcriptional complexes
capable of activating reporters in vitro.
Importantly, sd is required for tissue over-
growth and increased Hpo target gene
expression when yki is hyperactivated in
eye and wing tissue. However, the effects
of sd inactivation indicated differing re-
quirements for Sd according to cell type.
Mutant sd clones generated in eye, wing
hinge, and notal (thoracic) tissue dis-
played no defects in growth or Hpo path-
way target gene expression, suggesting
that Sd does not normally regulate growth
in these cell types. Clonal analysis in the
wing blade, however, showed that Sd is
essential for growth there, and also re-
vealed effects on Hpo target gene expres-
sion. Remarkably, Jiang’s team observed
decreased growth and target gene ex-
pression in all regions of eyes and wings
when sd was depleted by RNAi, implying
that Sd may be reduced to a greater ex-
tent by this method. Combined, these
data suggest that sd is required for theDevelopmental Cnormal basal expression of genes that
can be suppressed by Hpo signaling,
and has its greatest impact in the de-
veloping wing blade.
So, how does Yki-Sd activate genes
suppressed by Hpo signaling? This regu-
lation appears to be direct, as both
groups demonstrated that Sd binds to
DNA at the best-characterized target,
diap1. Two different DNA sequences at
the diap1 locus were identified that are
involved in responding to Sd and Yki.
These experiments represent the first
demonstration of direct transcriptional
control of an Hpo-responsive gene by
Yki. Further experiments are needed to
test other known Hpo target genes, such
as cycE, ex, and bantam, for direct regula-
tion by Yki and Sd.
Sd not only recruits Yki to DNA, but also
promotes its nuclear localization. Hpo sig-
naling inhibits Yki by cytoplasmic seques-
tration (Dong et al., 2007), so Jiang and
colleagues asked whether Sd shuttles
Yki into the nucleus. They demonstrated
that Sd increased the nuclear localization
of tagged Yki, and contend that this re-
quires physical interaction with Sd. Simi-
lar observations from the Zider lab have
also recently been published (Goulev
et al., 2008). Pan’s group isolated a yki
allele with a mutation that abrogates Sd
binding, which could be used to confirm
that binding to Sd is indeed required for
Yki nuclear localization.
Sd is also a DNA-binding partner for
Vestigial (Vg), a regulatory gene required
for wing formation. Together, Vg and Sd
control the transcription of wing pattern-
ing genes (Halder et al., 1998). Thus,
a question raised by the new findings is
how Yki-Sd and Sd-Vg select their partic-
ular target genes. Yki and Vg may allowell 14, March 2008 ª2008 Elsevier Inc. 315
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PreviewsFigure 1. The Hippo Signaling Pathway
Fat, Mer, Ex, and potentially other upstream regu-
lators stimulate the kinase activity of Hpo, which
phosphorylates and activates Wts. Wts then phos-
phorylates Yki Ser168, inducing 14-3-3-dependent
cytoplasmic localization and inactivation of Yki.
When Hpo signaling is off, Yki enters the nucleus.
In some cell types, Yki associates with target
DNA via Sd, perhaps together with Vg (denoted
by [?]). Yki may also associate with other transcrip-
tion factors at different promoters or in different
cell types (denoted by [??]). Figure adapted from
Zhang et al. (2008).Signaling to Nucle
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The nucleocytoplasmic transport of many
macromolecules depends upon Ran,
a small GTPase of the Ras superfamily.
Ran is concentrated in the nucleus where
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target genes, and indeed there is evi-
dence that Vg can change the target
specificity of Sd (Halder and Carroll,
2001). Zider and colleagues (Goulev et al.,
2008) report, however, that Yki stim-
ulates the transcription of genes regulated
by Sd-Vg, such as vg itself and dE2F1.
Consistently, Pan’s group found that
overexpressed yki or vg partially rescues
the growth defects of vg or yki mutant
clones, respectively. This suggests that
Yki-Sd and Sd-Vg may not bind separate
targets, but instead function in a coopera-
tive manner with Yki, Vg, and Sd at the
same sets of target promoters (Figure 1).
Future studies will have to test, for
example, if Vg is also bound at the diap1
locus.
Does Yki associate with transcription
factors other than Sd to mediate the re-
sponse to Hpo signaling? This hasn’t
been tested, but it seems likely. Two-
hybrid analysis has predicted Yki binding
partners in addition to Sd (Giot et al.,
2003); Sd is not expressed in all the cell
types that respond to the loss of Hpo
signaling (Campbell et al., 1992), and yki
mutant cells have more severe growth
defects than sd mutant cells (Huang
et al., 2005). These observations all
indicate that factors in addition to
Sd must function with Yki. Identifying
these will be a major avenue of future
research.ar Transport
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